Regenerative Medical Technology (RMTG) Notes Payables (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Notes Payables of $47452.0 for Q1 2026, down 99.73% year-over-year from $17.7 million in Q1 2025, and little changed quarter-over-quarter from $47452.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Notes Payables (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Notes Payables history runs 10 years deep, the most recent figure standing at $47452.0 for Q1 2026.
- In Q1 2026, Notes Payables fell 99.73% year-over-year to $47452.0; the TTM figure through Mar 2026 stood at $47452.0 (down 99.73% YoY), while the FY2025 annual figure was $47452.0, up 911.99% from the prior year.
- Notes Payables for Q1 2026 stood at $47452.0, roughly flat from $47452.0 in the prior quarter.
- The five-year high for Notes Payables was $17.7 million in Q1 2025, with the low at $2146.0 in Q4 2023.
- The 5-year median for Notes Payables is $2.4 million (2024), against an average of $5.7 million.
- Peak annual rise in Notes Payables reached 11295.13% in 2023, while the deepest fall reached 99.97% in 2023.
- Regenerative Medical Technology's Notes Payables stood at $7.0 million in 2022, then plunged by 99.97% to $2146.0 in 2023, then soared by 118.5% to $4689.0 in 2024, then surged by 911.99% to $47452.0 in 2025, then changed by 0.0% to $47452.0 in 2026.
- Business Quant data shows RMTG's Notes Payables at $47452.0 in Q1 2026, $47452.0 in Q4 2025, and $43138.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Regenerative Medical Technology | 919,727.76 | -141,720.24 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,452.00 |
| Dec 31, 2025 | 47,452.00 |
| Sep 30, 2025 | 43,138.00 |
| Jun 30, 2025 | 17.72 Mn |
| Mar 31, 2025 | 17.72 Mn |
| Dec 31, 2024 | 4,689.00 |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 17.27 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 2,146.00 |
| Sep 30, 2023 | 16.97 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 7.07 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 62,252.00 |
| Mar 31, 2022 | 72,252.00 |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 914,253.00 |